General MedicationsINJECTIONStandard
ZYMFENTRA
INFLIXIMAB-DYYB
Standard Dose
120MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary
Approval overview ZYMFENTRA is listed in Drugs@FDA under application 761358 (BLA).
Review priority: N/A Marketing status: Prescription Active ingredient INFLIXIMAB-DYYB Form and strength INJECTABLE;INJECTION - 120MG/ML Sponsor CELLTRION Submission history Latest submission status date: 2024-02-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview ZYMFENTRA is listed in Drugs@FDA under application 761358 (BLA). Review priority: N/A Marketing status: Prescription Active ingredient INFLIXIMAB-DYYB Form and strength INJECTABLE;INJECTION - 120MG/ML Sponsor CELLTRION Submission history Latest submission status date: 2024-02-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.